RxDoctor Payments DataLook up a doctor →

Arnold Silva

Nephrology · Meridian, IDNPI 1497790646

Payments from drug & device makers

$3,079,677in general payments, 2019–2025

Across 2,026 payments — averaging $1520.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Akebia Therapeutics Inc$612K
  • GSK$481K
  • Travere Therapeutics, Inc.$375K
  • Boehringer Ingelheim$312K
  • AstraZeneca$259K
  • Bayer$197K
  • plus $844K from 31 others
$1,529in research payments, 2019–2025

Across 9 payments — averaging $169.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Akebia Therapeutics Inc667$611,601
GSK149$480,865
Travere Therapeutics, Inc.354$374,928
Boehringer Ingelheim54$312,382
AstraZeneca(2 entities)207$258,952
Bayer140$197,391
Vertex2$195,965
Biogen2$95,479
Gilead20$72,859
Takeda Pharmaceuticals U.S.A., Inc.12$65,652
Pfizer17$63,345
Novartis29$61,528
Lilly USA, LLC37$45,076
Amgen(2 entities)81$43,563
Aurinia Pharma U.S., Inc.36$30,742
OPKO Pharmaceuticals, LLC15$21,889
Apellis Pharmaceuticals, Inc.21$20,527
Vifor Pharma, Inc.29$19,914
Alnylam Pharmaceuticals Inc.5$19,800
AbbVie(2 entities)2$19,597
Otsuka Pharmaceutical Development & Commercialization, Inc.11$19,068
Ardelyx, Inc.19$16,579
Boehringer Ingelheim Pharma GmbH & Co.kg38$5,793
Fresenius USA Marketing, Inc.4$4,541
Eli Lilly2$4,500
Boehringer Ingelheim International GmbH19$3,999
Calliditas Therapeutics US Inc.20$3,944
Boehringer Ingelheim Limited5$3,682
Johnson & Johnson6$2,729
CSL Behring2$1,973
Otsuka America Pharmaceutical, Inc.14$543
Sanofi2$150
Sobi, Inc1$36
Mallinckrodt Hospital Products Inc.1$27
Genentech, Inc.1$25
Novo Nordisk1$18
Genentech USA, Inc.1$14

How this compares

$3,079,677 in reported general payments places this provider in the 95th percentile of 30 nephrology providers in Idaho.

See all nephrology providers in Idaho →

Other nephrology in Meridian

See the full list for Idaho →

Where these figures come from

Is this you, or does something look wrong? →